Amgen Inc. Other Comprehensive Income, Other, Net of Tax
Amgen Inc. (AMGN) reported Other Comprehensive Income, Other, Net of Tax of $1.00 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-10-28.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeOtherNetOfTax · last filed 2016-10-28
- Amgen Inc. other comprehensive income, other, net of tax for the quarter ending 2016-09-30 was $1.00M, a 80.00% decline year-over-year.
- Amgen Inc. other comprehensive income, other, net of tax for the quarter ending 2016-06-30 was $1.00M.
- Amgen Inc. other comprehensive income, other, net of tax for the quarter ending 2015-09-30 was $5.00M.
- Amgen Inc. other comprehensive income, other, net of tax for the quarter ending 2015-06-30 was $0.00.
| Period end | Other Comprehensive Income, Other, Net of Tax 3 month | Other Comprehensive Income, Other, Net of Tax 6 month | Other Comprehensive Income, Other, Net of Tax 9 month |
|---|---|---|---|
| 2016-09-30 | $1.00M 10-Q · filed 2016-10-28 | $2.00M derived: sum of 2 quarters · filed 2016-10-28 | $2.00M 10-Q · filed 2016-10-28 |
| 2016-06-30 | $1.00M 10-Q · filed 2016-10-28 | $1.00M 10-Q · filed 2016-07-29 | |
| 2015-09-30 | $5.00M 10-Q · filed 2016-10-28 | $5.00M derived: sum of 2 quarters · filed 2016-10-28 | $5.00M 10-Q · filed 2016-10-28 |
| 2015-06-30 | $0.00 10-Q · filed 2016-07-29 | $0.00 10-Q · filed 2016-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |